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doi:10.1016/j.jtcvs.2006.03.014ackground: Right ventricular outflow tract obstruction can be a cause of hemo-
ynamic instability but it has not been described in non-congenital cardiac surgery.
ethods: The prevalence of right ventricular outflow tract obstruction was
etrospectively studied in 670 consecutive patients undergoing cardiac surgery.
ignificant right ventricular outflow tract obstruction was diagnosed if the right
entricular systolic to pulmonary artery peak gradient was more than 25 mm Hg.
he diagnosis was based on measurement of the right ventricular and pulmonary
rtery systolic pressure through the paceport and distal opening of the pulmo-
ary artery catheter. To further validate the prevalence and the importance of
ight ventricular outflow tract obstruction, 130 patients were prospectively
tudied over a 12-month period.
esults: In the retrospective cohort, 6 patients (1%) undergoing various types of
ardiac surgical procedures were found to have significant dynamic right ventricular
utflow tract obstruction with a mean gradient of 31 4 mm Hg (26 to 35 mm Hg).
n the prospective study significant dynamic right ventricular outflow tract obstruc-
ion was identified in 5 patients (4%) (average peak: 37  15 mm Hg; range: 27 to
0 mm Hg). The typical transesophageal echocardiography finding was end-systolic
bliteration of the right ventricular outflow tract. In patients with significant dy-
amic right ventricular outflow tract obstruction, hemodynamic instability was
resent in 10/11 patients (91%).
onclusions: Right ventricular outflow tract obstruction is easily diagnosed using
he paceport of the pulmonary artery catheter and should be considered as a potential
ause of hemodynamic instability especially when transesophageal echocardiogra-
hy reveals systolic right ventricular cavity obliteration.
emodynamic instability after cardiac surgery has various etiologies includ-
ing ventricular dysfunction, hypovolemia, tamponade, left ventricular out-
flow tract (LVOT) obstruction and sometimes a combination of 
actors.1 Right ventricular outflow tract (RVOT) obstruction, which can be d
xtrinsic2-4 or intrinsic causes,5-7 can also result in hemodynamic instability. A
ording to time-honoured hemodynamic criteria, RVOT obstruction is defined as
significant” when the peak right ventricular to pulmonary artery systolic gradient
xceeds 25 mm Hg.8 Furthermore, on transesophageal echocardiography (TEE
ignificant RVOT obstruction is defined as “fixed” if there is no change in RVOT
imensions during the cardiac cycle with anatomic substrate for obstruction, and as
dynamic” if RVOT dimensions increase appreciably in diastole. Dynamic RVOT
bstruction has been observed in hypertrophic cardiomyopathy9 and after lung
ransplantation10,11 but it has rarely been described during cardiac surgery.12 Over
3-year period, new-onset significant dynamic RVOT obstruction was seen in 11
atients undergoing cardiac surgery. The diagnosis of RVOT obstruction was made
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left ventricular hypertrophy; m, male; min, minutes; MVR, mitral valve repair; PH
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A
CDsing continuous right ventricular pressure and pulmonary
rtery pressure monitoring. After having identified and
haracterized this anomaly in a retrospective study, we
ypothesized that this new knowledge integrated in a sys-
emic hemodynamic and echocardiographic assessment
ould allow determination of a higher but correct incidence
f this problem in a prospective study. Our objective was
lso to better understand the mechanism and risk factors
nvolved in the appearance of RVOT obstruction.
DSB Details Outcome
Y Return on CPB 3 times,
intra-aortic balloon
pump inserted.
Noradrenaline 66 g/
min, adrenaline 4 g/
min, vasopressine 2
units/hour, nitric oxide
20 ppm, milrinone 50
g/kg and dopamine 5
g/kg/min. Milrinone
and dopamine were
discontinued once the
diagnosis was made
Develop acute renal failure,
and acute respiratory
distress syndrome,
vasoactive support for 24
hours, hospitalisation 20
days
Y Noradrenaline 13 g/min,
vasopressin 2 units
bolus and nitroglycerine
1.3 g/kg/min, inhaled
prostacyclin 60 g,
milrinone 50 g/kg,
methylene blue 50 mg
Vasoactive support for 10
hours, hospitalisation 10
days
Y Noradrenaline 2.5 g/min,
inhaled prostacyclin 60
g and inhaled
milrinone 5 mg,
nitroglycerine 0.5 g/kg/
min
Vasoactive support 3 hours,
hospitalisation 8 days
Y Noradrenaline 10 g/min,
vasopressine 2 units
bolus, milrinone 50 g/
kg, methylene blue 100
mg
Vasoactive support 3 hours,
ventricular tachycardia
requiring pace-
defibrillator,
hospitalisation 19 days
Y Noradrenaline 12.5 g/
min, nitroglycerine 0.7
g/kg/min
Vasoactive support 20
hours, acute renal
failure, hospitalisation 18
days
Y Noradrenaline 7.5 g/kg,
nitroglycerine 0.7 g/kg/
min, milrinone 50 g/kg
Vasoactive support 2 hours,
hospitalisation 6 days
aration from CPB (details in Table 4); f, female; HTN, hypertension; LVH,ABLE 1. Retrospective series
Age Sex Procedure
Predisposing
factor HTN PHT
CPB
duration
(min)
1 75 m Coronary
revascularization
and AVR
Inotropes and
LVH
Y N 147
2 46 f Coronary
revascularization
and aortic
surgery
Inotropes and
LVH
N Y 346
3 58 m AVR, MVR, aortic
surgery
Inotropes and
LVH
N Y 205
4 51 m AVR, VSD closure,
aortic surgery
Inotropes N Y 129
5 62 m Septal
myomectomy,
aortic surgery
Septal
hypertrophy
Y N 86
6 68 m Coronary
revascularization
Inotropes and
LVH
Y N 93
VR, aortic valve replacement; CPB, cardiopulmonary bypass; DSB, difficult sepAbbreviations and Acronyms
AVR  aortic valve replacement
CPB  cardiopulmonary bypass
HTN  hypertension
LVOT  left ventricular outflow tract
RVOT right ventricular outflow tract
TEE  transesophageal echocardiographyT, pulmonary hypertension; VSD, ventricular septal defect.
006
M
A
i
i
g
s
p
r
w
p
m
v
a
p
c
p
c
p
T
p
t
a
w
T
a s
b
l
p
t
a
s
d
t
m
a
p
i c
f opp
l
v
a
m
v
b
e
o
i
t
p
p
s m.
L
c e
r
1
c
p
o
c
s
e
o
(  care
u
o
T
d
p
M
p
p
i
a
R
F
6
h
t
b
c 60 
1
a
F
m
w
b
H
v
s
l
P
v
Denault et al Surgery for Acquired Cardiovascular Disease
A
CDethods
fter approval by the Research and Ethics Committees of our
nstitution, the Department of Anesthesia has maintained for qual-
ty control purpose, a TEE database since 1999 to store demo-
raphic, hemodynamic and echocardiographic data. Informed con-
ent was obtained from all patients for intraoperative use of
ulmonary artery catheterization and TEE. Since August 2002, a
etrospective analysis of all patients undergoing cardiac surgery
as performed. Demographic data included age, gender and the
resence of hypertension defined through patient’s history and
edications. All these patients were monitored by continuous right
entricular pressure waveform analysis through the pulmonary
rtery catheter paceport (Edwards Lifescience, Irvine, Ca). The
aceport opening is located at 19 cm from the distal end of the
atheter. Transducers extension tubing are connected to the distal
ort and to the paceport of the pulmonary artery catheter. The
atheter is advanced until the hemodynamic curve from the pace-
ort changes from an atrial to a ventricular pressure waveform.
hen the catheter is maintained in this position throughout the
rocedure therefore allowing continuous monitoring of right ven-
ricular and pulmonary artery pressure waveforms. In all patients,
fter the induction of anesthesia, routine hemodynamic waveforms
ere acquired during insertion of the pulmonary artery catheter.
he normal gradient between right ventricular and pulmonary
rtery systolic pressure is 0 to 3 mm Hg13 and peak gradient
etween 3 and 25 mm Hg are often considered trivial based on the
iterature pertaining to chronic RVOT obstruction. In contrast,
eak gradients above 25 mm Hg are considered significant8 d
his cut-off value was used in this study. The gradient is calculated
s the difference between the peak systolic right ventricular pres-
ure and peak systolic pulmonary artery pressure using the hemo-
ynamic tracing or directly calculated from the monitor. In addi-
ion to pulmonary artery catheterization, perioperative TEE
onitoring (Philips, Sonos 5500, Andover, Ma) was performed by
cardiac anesthesiologist trained and board-certified in TEE in all
atients undergoing cardiac surgery. The echocardiographic exam
ncluded the recommended views,14 the evaluation of diastoli
unction15 and the interrogation of all four valves by color D-
er. Color Doppler imaging in the mid-oesophageal four-chamber
iew between 0 to 70° was used to detect tricuspid regurgitation
nd continuous-wave Doppler was positioned to obtain the maxi-
um regurgitant jet to measure the peak tricuspid regurgitant
elocity. This peak velocity reflects the peak pressure gradient
etween the right ventricle and right atrium through the Bernouilli
quation.16
Echocardiographic images suggestive of the abnormal RVOT
bstruction were obtained through 2D echocardiography using a
nflow-outflow view of the right ventricle or through a deep
ransgastric view at 40° as previously described.17
Pulmonary hypertension was defined as a preoperative mean
ulmonary artery pressure above 25 mm Hg obtained during
reoperative catheterization or a systolic pulmonary artery pres-
ure above 30 mm Hg18 measured directly in the operating roo
eft ventricular hypertrophy was determined using either electro-
ardiographic findings19 or the following echocardiographic crit-
ia: posterior wall thickness 12 mm, left ventricular mass above
31 g/m2 in men or 110 g/m2 in women. Difficult separation from
ardiopulmonary bypass (CPB) was identified as systolic blood t
The Journal of Thoracressure80 mm Hg, confirmed by central measurement (femoral
r aortic), diastolic pulmonary artery pressure or pulmonary artery
apillary wedge pressure 15 mm Hg, and inotropic or vasopres-
ive support for more than 1 hour (norepinephrine 4 g/min,
pinephrine 2 g/min, dobutamine 2 g/kg min1) or the use
f milrinone, mechanical support or intra-aortic balloon pump
IABP)1,20,21 to wean from CPB until transfer to the intensive
nit. All echocardiographic recordings were stored on magnetic
ptical disk and the examination findings stored in the database.
he hemodynamic tracings were recorded on videotape. Finally to
etermine the precise incidence of RVOT obstruction, in the
rospective series, 130 patients operated from September 2004 to
ay 2005 were continuously monitored using the paceport of the
ulmonary artery catheter from the beginning to the end of the
rocedure. Chi-square test was used to compare RVOT obstruction
n patients with or without difficult separation from CPB. The data
re reported as mean  standard deviation.
esults
rom August 2002 to September 2004, a total of 8 out of
70 consecutive patients undergoing TEE were found to
ave a RVOT gradient 25 mm Hg. Two patients had
ransient mechanical RVOT obstruction during off-pump
ypass surgery and were excluded from the analysis. Patient
haracteristics are listed in Table 1. The mean age was 
1 years, the mean duration of CPB was 168  97 minutes
nd the average peak gradient was 31 4 mm Hg (range 26
igure 1. Septal myomectomy and aortic surgery in a 68-year-old
an complicated by dynamic RVOT obstruction appearing during
eaning from cardiopulmonary bypass. (A)The systolic gradient
etween the right ventricle and the pulmonary artery was 28 mm
g. (B,C,D) An M-mode view from a mid-oesophageal right-
entricular inflow-outflow view at 63° is illustrated with the
ystolic dynamic obstruction of the right ventricular outflow (LA,
eft atrium; Pa, arterial pressure; Ppa, pulmonary artery pressure;
rv, right ventricular pressure; RA, right atrium; RV, right
entricle).o 35 mm Hg). In all these 6 patients (1%), RVOT obstruc-
ic and Cardiovascular Surgery ● Volume 132, Number 1 45
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A
CDABLE 2. Prospective series
Age Sex Procedure
Predisposing
factor HTN PHT
CPB
duration
(min) DSB Details Outcome
1 26 F AVR and aortic
pseudoaneurysm
repair
Inotropes N N 138 Y Noradrenaline 4 g/min,
vasopressine 2 units/h,
nitroglycerine 0.14
g/kg/min, inhaled
milrinone 5 mg
Vasoactive support for 40
hours, hospitalisation
21 days
2 61 M Coronary
revascularization
None Y N 69 No Noradrenaline 2.5 g/kg/
min, vasopressine 3
units bolus
Vasoactive support 3
hours, hospitalisation 5
days
3 24 M Repeated aortic
surgery (Cabrol)
Inotropes N N 208 Y Noradrenaline 9 ug/min,
nitroglycerine 0.3 g/
kg/min, vasopressine
bolus 2 units, calcium
chloride1 gm
Vasoactive support for 20
hours, death from
severe heart failure
from myocardial
infarction 6 days later
despite left ventricular
assist device
4 46 M Heart
transplantation
Inotropes N Y 121 Y Noradrenaline 25 g/
min, nitroglycerine 0.7
g/kg/min, milrinone
50 g/kg, inhaled
prostacyclin 60 g,
adrenalin 2 g/min,
vasopressine 2 units/
hour, isoproterenol 3
g/min
Vasoactive support for 27
days, hospitalisation
119 days
5 68 M AVR LVH,
inotropes
Y N 168 Y Noradrenaline 30 g/
min, nitroglycerine 0.2
g/kg/min, inhaled
milrinone 5 mg,
ephedrine 5 mg,
vasopressine 1 unit
bolus
Had unexplained
hypotension requiring
vasoactive support for
3 days, hospitalisation
9 days
VR, aortic valve replacement; CPB, cardiopulmonary bypass; DSB, difficult separation from CPB; HTN, hypertension; LVH, left ventricular hypertrophy; min,
inutes; PHT, pulmonary hypertension.ABLE 3. Hemodynamic conditions during RVOT obstruction
etrospective series HR (beats/min) Pa (mm Hg) Ppa (mm Hg) Systolic Prv (mm Hg) RVOT Gradient (mm Hg) Pra (mm Hg)
atient 1 91 86/44 (68) 34/22 (24) 69 35 20
atient 2 95 118/42 (59) 21/11 (15) 47 26 11
atient 3 100 113/56 (76) 29/17 (22) 59 30 13
atient 4 71 85/55 (65) 55/27 (38) 90 35 15
atient 5 80 paced 159/84 (109) 32/22 (26) 60 28 6
atient 6 125 116/48 (70) 18/11 (14) 48 30 8
rospective series
atient 1 93 108/74 (88) 25/18 (20) 52 27 18
atient 2 90 123/57 (79) 27/14 (20) 54 27 12
atient 3 100 112/40 (55) 18/11 (15) 62 44 8
atient 4 94 117/69 (86) 39/21 (28) 67 28 8
atient 5 103 123/51 (70) 18/9 (14) 78 60 4
VOT, right ventricular outflow tract; HR, heart rate; Pa, arterial pressure; Ppa, pulmonary artery pressure; Prv, right ventricular pressure; Pra, right atrial
ressure.
6 The Journal of Thoracic and Cardiovascular Surgery ● July 2006
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CDion occurred after CPB and was associated with systolic
bliteration in the RVOT (Figure 1). In most of 
atients, the gradient improved or normalized as the right
entricular preload was increased and the inotropic agents
ere decreased or discontinued.
In the prospective study (Table 2), a total of 6 pa
ut of 130 had significant RVOT obstruction. One patient
ad RVOT obstruction during ventricular mapping sec-
ndary to cardiac manipulation and was excluded. Five
atients (4%) were therefore found to have new-onset
ignificant dynamic RVOT obstruction after CPB. The
ean age of the patients was 45  20 years, the mean
igure 2. A 68-year-old man underwent aortic valve replacement.
e became hemodynamically unstable with right ventricular dys-
unction and went back on cardiopulmonary bypass. Inotropes
ere started. On the second weaning attempt, he developed
evere right ventricular outflow tract obstruction confirmed with
he paceport of the pulmonary artery catheter and through con-
inuous-wave Doppler interrogation of the tricuspid regurgitant
ow in a mid-oesophageal right ventricular inflow-outflow view
t 61°. The measured pressure gradient of the tricuspid regurgi-
ant flow was 75 mm Hg (with a right ventricular systolic pressure
f 80 mm Hg) and the pulmonary artery pressure (Ppa) was 30/16
m Hg during the echocardiographic measurement. (EKG, elec-
rocardiogram; Pa, arterial pressure; Prv, right ventricular
ressure).
ABLE 4. Criteria for significant right ventricular outflow t
emodynamic findings
ystolic right ventricular to pulmonary artery gradient 25 mm H
-combined pulmonary artery and right ventricular pressure mon
-pulmonary artery catheter pullback in the right ventricle if pac
chocardiographic findings consistent with RVOT obstruction
First exclude other mechanisms of hemodynamic instability
-mode: Mid-oesophageal inflow-outflow view showing obliterat
wo-dimensional:
Mid-oesophageal inflow-outflow view showing obliteration of t
Deep transgastric view with right-sided rotation 40° showing R
olor Doppler:
Aliasing in the RVOT in the mid-oesophageal right ventricular i
ontinuous-wave Doppler:
Transtricuspid pressure gradient  systolic pulmonary artery p
ulsed-wave Doppler:
Atrial-reversal velocity more than 50% of the systolic velocity of the
The Journal of Thoracs
uration of CPB was 141  52 minutes and the average
eak gradient was 37  15 mm Hg (range 27 to 60 mm
g). The hemodynamic conditions of both groups of
atients at the time that the RVOT obstruction was ob-
erved are described in Table 3. The average heart
as 96  13 beats/min, systolic, diastolic and mean
ystemic arterial pressures were 114  20, 56  14 and
5  15 mm Hg, systolic, diastolic and mean pulmonary
rtery diastolic pressures were 29  11, 17  6 and 21 
mm Hg. The average systolic right ventricular and right
trial pressures were 63  13 mm Hg and 11  5 mm Hg.
he mean gradient was 34  10 mm Hg (range 26 to 60
m Hg). Difficult separation from CPB was observed in
1% of the 670 patients in the retrospective group, in
6% of the 130 patients of the prospective group and in
1% of patients with dynamic RVOT obstruction (P 
0014). The drugs required for weaning from CPB, the
uration of vasoactive support and the outcome are de-
cribed in Table 1 & 2. In 3 patients in whom a Doppler
ricuspid regurgitant jet could be measured, the pressure
radient estimated with the simplified Bernoulli equation
as superior to the pulmonary artery pressure (Figure
iscussion
he observed prevalence of significant dynamic RVOT
bstruction in the study was 1% in the retrospective cohort,
hile it was 4% in the prospective cohort. In 10/11 patients
91%) RVOT obstruction was associated with difficult sep-
ration from CPB from hemodynamic instability. The diag-
ostic criteria of RVOT obstruction and the associated
chocardiographic findings observed in the study are sum-
arized in Table 4.
Right ventricular outflow tract obstruction was docu-
ented in all patients through right ventricular pressure
onitoring, with direct pressure measurements in the
(RVOT) obstruction
asured through
ng
t unavailable.
f the RVOT
OT
obliteration
-outflow view with/without M-mode
ureract
g me
itori
epor
ion o
he RV
VOT
nflow
resshepatic venous flow suggestive of right ventricular impairment.
ic and Cardiovascular Surgery ● Volume 132, Number 1 47
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A
CDulmonary artery and right ventricle. Systolic oblitera-
ion of the RVOT was seen with TEE in the mid-oesoph-
geal right ventricular inflow-outflow tract view. Right
entricular systolic pressure derived from continuous
oppler interrogation of the tricuspid valve and central
enous pressure also revealed that the right ventricular
aximal systolic pressure was higher than the pulmonary
rtery systolic pressure.
he Association Between RVOT Obstruction and
emodynamic Instability
xtrinsic RVOT obstruction has been recognized as a 
ible cause of hemodynamic instability17 after cardiac sur-
ery. Extrinsic compression can occur from an aortic2 or
ulmonary artery aneurysm,3 mediastinal hematoma4 or di-
ect surgical compression during off-pump surgery. In con-
rast, intrinsic obstruction has been described with congen-
tal heart disease,5,6-7 hypertrophic cardiomyopathy9 and
fter lung transplantation.10,11
New onset dynamic subvalvular RVOT obstruction, as
as observed in this study, usually occurs in the setting of
educed preload, hypertrophied right ventricle and in pa-
ients on inotropic therapy.10 In our series inotropic agen
nd left ventricular hypertrophy were present in 10 patients
91%). The occurrence of dynamic RVOT obstruction in a
atient on inotropic therapy could contribute to hemody-
amic instability. This conclusion is based on the fact that
urther deterioration of the hemodynamic status of the pa-
ients in the study was often associated with the develop-
ent of significant RVOT obstruction. In this circumstance,
ptimisation of right ventricular preload instead of increas-
ng inotropic therapy, improved the clinical status of the
atients.
Although uncommon, the presence of significant dy-
amic RVOT obstruction should be suspected in any hemo-
ynamically unstable patients receiving inotropes. In our
atients, none had a significant right ventricular to pulmo-
ary artery systolic gradient before CPB and inotropes were
sed only after CPB for weaning. The average CPB time
as more than 2 hours which increases the risk of cardiac
unction impairment and may explain why the anesthesiol-
gist considered using inotropic agents. These agents were
topped once the diagnosis of RVOT obstruction was made.
he administration of inotropic agents may have promoted
VOT obstruction in our study. It should be emphasized
hat significant RVOT obstruction can also occur without
ny preoperative risk factor as we observed in one patient.
n the operating room, continuous right ventricular pressure
onitoring through the pacemaker port represents an easier
ethod to rapidly diagnose RVOT obstruction compared to
ulling back the pulmonary artery catheter in the right
entricle. In the latter situation, ventricular arrhythmias can
ccur, which we did not observe using the paceport catheter
s a continuous pressure monitor.
8 The Journal of Thoracic and Cardiovascular Surgery ● July 2Pathophysiologically, dynamic RVOT obstruction can be
xplained by the increased susceptibility of the infundibu-
um to inotropic agents. In fact, the inotropic response of the
nfundibulum is greater than that of the inflow tract, perhaps
s a mechanism to protect the pulmonary vasculature from
igh pressure.22,23 This differential response could expla
he presence of dynamic RVOT obstruction in patients on
notropes or during cardiac surgery. Moreover, the coordi-
ated sequence of activation of the right ventricle can also
e reversed by the post-operative hyperadrenergic state24
n normal conditions, right ventricular contraction is se-
uential starting with the contraction of the trabeculated
yocardium and ending with that of the infundibulum (ap-
roximately 25 to 50 milliseconds later). In the presence of
ympathetic stimulation or norepinephrine infusion the nor-
al sequence of activation may be abolished and RV inflow
ontraction can even occur after infundibular contraction.
There are several limitations from this case series. The
iagnosis of RVOT obstruction was unexpected and most of
he time was associated with hemodynamic instability.
herefore we did not have the opportunity to obtain a
etailed hemodynamic profile. This is why we only reported
he maximal gradient that occurred at that time. The number
f patients is also too small to make generalisation about the
est therapeutic approach but in all our patients, except the
ne undergoing heart transplantation, the inotropes were
topped and avoided in the post-operative period. However,
he interest of our findings lies at this point in the knowledge
f this entity when faced with patients with hemodynamic
nstability after CPB and the potential correct therapy.
In summary, dynamic RVOT obstruction can occur in
everal types of cardiac surgery. The diagnosis is e
btained with continuous right ventricular and pulmonary
rtery pressure monitoring, and can also be suspected with
EE. In cardiac surgical patients experiencing hemody-
amic instability, dynamic RVOT obstruction should be
onsidered especially when TEE reveals right ventricular
avity obliteration or turbulent flow patterns. The presence
f dynamic RVOT obstruction can contribute to hemody-
amic instability, and in that situation inotropic agents
ould be responsible for or could exacerbate this condition.
n our experience, preload optimization and inotropic agents
ithdrawal were successful in the management of this
ondition.
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